Eagle Pharmaceuticals Inc (EGRX)
0.50
-0.05
(-9.09%)
USD |
OTCM |
Nov 04, 16:00
Eagle Pharmaceuticals Total Liabilities (Quarterly): 152.78M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 152.78M |
| March 31, 2023 | 171.33M |
| December 31, 2022 | 172.60M |
| September 30, 2022 | 154.67M |
| June 30, 2022 | 143.77M |
| March 31, 2022 | 104.20M |
| December 31, 2021 | 77.28M |
| September 30, 2021 | 70.97M |
| June 30, 2021 | 69.40M |
| March 31, 2021 | 68.89M |
| December 31, 2020 | 67.18M |
| September 30, 2020 | 75.37M |
| June 30, 2020 | 72.75M |
| March 31, 2020 | 180.11M |
| December 31, 2019 | 75.38M |
| September 30, 2019 | 81.27M |
| June 30, 2019 | 89.15M |
| March 31, 2019 | 84.09M |
| December 31, 2018 | 77.84M |
| September 30, 2018 | 74.72M |
| Date | Value |
|---|---|
| June 30, 2018 | 88.21M |
| March 31, 2018 | 71.12M |
| December 31, 2017 | 90.92M |
| September 30, 2017 | 95.81M |
| June 30, 2017 | 54.82M |
| March 31, 2017 | 57.99M |
| December 31, 2016 | 63.09M |
| September 30, 2016 | 41.20M |
| June 30, 2016 | 41.53M |
| March 31, 2016 | 36.38M |
| December 31, 2015 | 34.26M |
| September 30, 2015 | 34.59M |
| June 30, 2015 | 24.58M |
| March 31, 2015 | 27.05M |
| December 31, 2014 | 22.19M |
| September 30, 2014 | 20.32M |
| June 30, 2014 | 16.25M |
| March 31, 2014 | 19.27M |
| December 31, 2013 | 17.24M |
| September 30, 2013 | 16.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
67.18M
Minimum
Dec 2020
180.11M
Maximum
Mar 2020
110.45M
Average
77.28M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Verrica Pharmaceuticals Inc | 65.31M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 404.82M |
| Shareholders Equity (Quarterly) | 252.04M |